XML 45 R4.htm IDEA: XBRL DOCUMENT v3.19.3.a.u2
Condensed Consolidated Statements of Operations - USD ($)
shares in Thousands, $ in Thousands
 3 Months Ended 9 Months Ended
Mar. 31, 2019
Mar. 31, 2018
Mar. 31, 2019
Mar. 31, 2018
Income Statement [Abstract]        
Net sales (including related party sales of $17,590 and $17,614 in the three months ended March 31, 2019 and 2018, respectively, and $48,849 and $46,199 in the nine months ended March 31, 2019 and 2018, respectively) $ 743,499 $ 835,110 $ 2,646,126 $ 2,378,830
Cost of sales (including related party purchases of $62,624 and $62,861 in the three months ended March 31, 2019 and 2018, respectively, and $215,331 and $191,805 in the nine months ended March 31, 2019 and 2018, respectively) 631,172 729,193 2,282,638 2,081,165
Gross profit 112,327 105,917 363,488 297,665
Operating expenses:        
Research and development 44,800 42,284 133,718 122,496
Sales and marketing 18,494 18,893 56,463 53,684
General and administrative 36,174 23,555 106,214 68,286
Total operating expenses 99,468 84,732 296,395 244,466
Income from operations 12,859 21,185 67,093 53,199
Other (expense) income, net (86) (388) 707 (1,578)
Interest expense (1,271) (1,326) (5,480) (3,497)
Income before income tax provision 11,502 19,471 62,320 48,124
Income tax provision (497) (4,159) (10,540) (25,725)
Income (Loss) from Equity Method Investments (359) (717) (3,572) (2,508)
Net income $ 10,646 $ 14,595 $ 48,208 $ 19,891
Net income per common share:        
Basic (in dollars per share) $ 0.21 $ 0.30 $ 0.97 $ 0.40
Diluted (in dollars per share) $ 0.21 $ 0.28 $ 0.94 $ 0.38
Weighted-average shares used in calculation of net income per common share:        
Basic (in shares) 49,988 49,425 49,845 49,285
Diluted (in shares) 51,558 51,679 51,557 52,090